期刊文献+

全身扩散加权成像在恶性淋巴结病变中的诊断价值 被引量:9

Diagnostic value of whole body diffusion weighted imaging in malignant lymphadenopathy
下载PDF
导出
摘要 目的探讨全身DWI(WB-DWI)在淋巴瘤与淋巴结转移瘤之间诊断及鉴别诊断的价值与意义。材料与方法筛选出经临床确诊的淋巴瘤患者25例,淋巴结转移瘤患者20例,同时选取15例健康志愿者作为对照组,均行WB-DWI及T2抑脂轴面扫描,记录所有异常淋巴结及正常对照组淋巴结的ADC值,将淋巴瘤组与正常组间、淋巴结转移瘤组与正常组间、淋巴瘤组与转移瘤组间ADC值进行两两比较,探讨ADC值在恶性淋巴结病变的诊断与鉴别诊断中是否具有显著性差异。试图根据受试者工作特征曲线(ROC曲线)分析确定淋巴瘤与淋巴结转移瘤间的最佳鉴别诊断阈值(OT)。结果淋巴瘤组ADC值为(0.70±0.13)mm2/1000 s,淋巴结转移组ADC值为(0.94±0.14)mm2/1000 s,正常对照组ADC值为(1.23±0.24)mm2/1000 s,经独立样本t检验,淋巴瘤组与淋巴结转移组间ADC值具有统计学意义(t=-16.395,P<0.05),淋巴瘤组与正常对照组间ADC值具有统计学意义(t=-14.876,P<0.05),淋巴结转移组与正常对照组间ADC值具有统计学意义(t=-7.851,P<0.05)。通过ROC曲线,得出在ADC值0.79时,AZ值=0.910,其对应灵敏度90.3%,特异度80.6%,此时准确指数最高,诊断效能最佳。结论全身DWI在全身恶性淋巴结病变的诊断中具有良好的应用前景,通过ADC值的定量分析能为两者的鉴别提供参考依据。 Objective: To study the value and significance of the body diffusionweighted imaging in the diagnosis and differential diagnosis between lymphoma and lymph node metastases. Material and Methods: Select 25 cases of clinically diagnosed lymphoma patients,20 patients with lymph node metastases,and 15 healthy volunteers as control group,all lines of WB-DWI imaging and T2 fat suppression shaft can scan,record ADC values of all abnormal lymph nodes and the lymph nodes in the normal control group,the lymphoma group and the normal group,lymph node metastasis group and the normal group,lymphoma group and metastasis between groups ADC value two two comparison,to investigate whether the ADC value has signifi cant differences in the diagnosis and differential diagnosis of malignant lymph node lesions. Try to determine the best differential diagnosis OT between lymphoma and lymph node metastasis under the receiver-operating characteristic curve(ROC curve) analysis. Results: Lymphoma group ADC value was(0.70±0.13) mm2/1000 s,lymph node metastasis group ADC value was(0.94±0.14) mm2/1000 s,normal control group ADC value was(1.23±0.24) mm2/1000 s,with the independent sample t test,lymphoma group with lymph node metastasis between groups ADC value with statistical significance(t=-16.395,P〈0.05),lymphoma group and normal control group ADC value with statistical significance(t=-14.876,P〈0.05),lymph node metastasis group and normal control group with statistical significance(t=-7.851,P〈0.05). By ROC curve we obtained that when the ADC value was 0.79,AZ value was 0.910,which corresponds to the sensitivity 90.3%,specificity 80.6%,this time accurate index was the highest and the diagnostic effi cacy best. Conclusions: Whole body diffusion weighted imaging has a good application prospect in diagnosis of systemic malignant lymphadenopathy,through quantitative analysis of ADC value can provide the reference basis for the distinction between the two.
出处 《磁共振成像》 CAS CSCD 2015年第3期213-217,共5页 Chinese Journal of Magnetic Resonance Imaging
基金 陕西省科学技术研究发展计划项目(编号:2012k13-02-18)
关键词 磁共振成像 弥散 淋巴瘤 淋巴结 Diffusion magnetic resonance imaging Lymphoma Lymph node
  • 相关文献

参考文献10

  • 1Lichy MP, Aschoff P, Plathow C, et al. Tumor detection by diffusion weighted MRI and ADC mapping initial clinical experiences in cpmparison to PET-CT. Invest Radial, 2007, 42(9): 605-613.
  • 2李琼,白人驹,邵宗鸿,邱录贵.应用DWI鉴别系统性淋巴瘤与淋巴结转移瘤[J].临床放射学杂志,2010,29(10):1372-1375. 被引量:7
  • 3Squillaci E, Manenti G, Cova M, et al. Correlation of diffusion weighted MR imaging with cellularity of renal tumours. Antieancer Res, 2004, 24(6): 4175-4179.
  • 4Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging, 2002, 16(2): 196-200.
  • 5Pickles MD, Gibbs P, Sreenivas M, et al. Diffusionweighted imaging of normal and malignant prostate tissue at 3.0 T. J Magn Reson Imaging, 2006, 23(2): 130-134.
  • 6龚红霞,路青,朱炯,范瑜,许建荣.3.0T MR ADC值与T2值定量测量在颈部淋巴瘤诊断价值的研究[J].磁共振成像,2012,3(5):367-371. 被引量:6
  • 7陈业媛,周战梅,何斌,刘干辉,陈福建,王进华,龚洪翰.DWI在单发性脑转移瘤、脑胶质瘤和脑脓肿鉴别诊断中的价值[J].实用临床医学(江西),2008,9(4):87-89. 被引量:18
  • 8Toh CH, Castillo M, Wong AM, et al. Prinary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol, 2008, 29(3), 471-475.
  • 9Hemeth AM, Guccione S, Bednarski M. Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radio, 2003, 45(3): 208-213.
  • 10龚红霞,许建荣.全身磁共振扩散加权成像在肿瘤中的应用[J].放射学实践,2009,24(3):341-344. 被引量:5

二级参考文献38

共引文献30

同被引文献97

  • 1李又成,李宗芳,李建策,李剑敏,田伟.原发性脑淋巴瘤的病理与MRI表现的相关研究[J].中国临床医学影像杂志,2005,16(1):5-7. 被引量:17
  • 2丁莹莹,李鹍,汪永平.淋巴结反应性增生的CT诊断[J].实用放射学杂志,2006,22(5):584-586. 被引量:11
  • 3徐贤,张金山,马林,蔡幼铨,程流泉,孙非,郭行高.3.0T磁共振全身扩散加权成像的正常表现和初步临床研究[J].中国医学影像技术,2007,23(6):793-796. 被引量:42
  • 4Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med, 2004, 22(4): 275-282.
  • 5Padhani AR, Koh DM, Collins DJ. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology, 2011,261(3): 700-718.
  • 6Li B, Li Q, Nie W, et al. Diagnostic value of whole-body diffusion- weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis. Eur J Radiol, 2014, 83(2): 338-344.
  • 7Michielsen K, Vergote I, Op de Beeck K, et al. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. ERr Radiol, 2014, 24(4): 889-901.
  • 8Kwee TC, Takahara T, Ochiai R, et al. Whole-body diffusion-weighted magnetic resonance imaging. Eur J Radiol, 2009, 70(3): 409-417.
  • 9Bittencourt LK, Matos C, Coutinho AJ. Diffusion-weighted magnetic resonance imaging in the upper abdomen: technical issues and clinical applications. Magn Reson Imaging Clin NAm, 2011, 19(1): 111-131.
  • 10Wilhelm T, Stieltjes B, Schlemmer HP. Whole-body-MR-diffusion weighted imaging in ontology. Rofo, 2013, 185(10): 950-958.

引证文献9

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部